These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 34702155

  • 1. Design, Synthesis, and Apoptosis-Promoting Effect Evaluation of Chalcone Derivatives Containing Aminoguanidine Units.
    Wang Y, Li L, Ma T, Cheng X, Liu D.
    Anticancer Agents Med Chem; 2022; 22(11):2116-2124. PubMed ID: 34702155
    [Abstract] [Full Text] [Related]

  • 2. Design, synthesis, and apoptosis-promoting effect evaluation of novel pyrazole with benzo[d]thiazole derivatives containing aminoguanidine units.
    Liu DC, Gao MJ, Huo Q, Ma T, Wang Y, Wu CZ.
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):829-837. PubMed ID: 30915869
    [Abstract] [Full Text] [Related]

  • 3. Synthesis and Anti-gastric Cancer Activity by Targeting FGFR1 Pathway of Novel Asymmetric Bis-chalcone Compounds.
    Nian C, Gan X, Liu Q, Wu Y, Kong M, Zhang P, Jin M, Dong Z, Li W, Wang L, He W, Li X, Wu J.
    Curr Med Chem; 2024 Dec; 31(39):6521-6541. PubMed ID: 38847254
    [Abstract] [Full Text] [Related]

  • 4. Design, synthesis and bioevaluation of novel prenylated chalcones derivatives as potential antitumor agents.
    Yu J, Wang X, Cheng S, Zeng X, Wan X, Wei S, Xu B, Luo H, Meng X.
    Eur J Pharm Sci; 2024 Jan 01; 192():106660. PubMed ID: 38052256
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and Biological Evaluation of Amino Chalcone Derivatives as Antiproliferative Agents.
    Lu CF, Wang SH, Pang XJ, Zhu T, Li HL, Li QR, Li QY, Gu YF, Mu ZY, Jin MJ, Li YR, Hu YY, Zhang YB, Song J, Zhang SY.
    Molecules; 2020 Nov 25; 25(23):. PubMed ID: 33255804
    [Abstract] [Full Text] [Related]

  • 6. Design, Synthesis and Bioactivity Evaluation of Novel Chalcone Derivatives Possessing Tryptophan Moiety with Dual Activities of Anti-Cancer and Partially Restoring the Proliferation of Normal Kidney Cells Pre-Treated with Cisplatin.
    He M, Yu M, Li C, Meng X, Su J, Zhu Y, Yao R.
    Anticancer Agents Med Chem; 2022 Nov 25; 22(10):1945-1961. PubMed ID: 34674626
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Synthesis of selenophene-based chalcone analogs and assessment of their biological activity as anticancer agents.
    Chen YC, Li CW, Chen JJ, Shih TL.
    Arch Pharm (Weinheim); 2023 Apr 25; 356(4):e2200486. PubMed ID: 36587972
    [Abstract] [Full Text] [Related]

  • 9. Design and development of novel 1,2,3-triazole chalcone derivatives as potential anti-osteosarcoma agents via inhibition of PI3K/Akt/mTOR signalling pathway.
    Su Q, Xu B, Tian Z, Gong Z.
    Acta Pharm; 2022 Sep 01; 72(3):389-402. PubMed ID: 36651540
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Design and Synthesis of Novel Chalcone Derivatives: Anti-Breast Cancer Activity Evaluation and Docking Study.
    Lai W, Chen J, Gao X, Jin X, Chen G, Ye L.
    Int J Mol Sci; 2023 Oct 25; 24(21):. PubMed ID: 37958533
    [Abstract] [Full Text] [Related]

  • 12. Synthesis, in vitro cytotoxicity evaluation and mechanism of 5' monosubstituted chalcone derivatives as antitumor agents.
    Xu X, Wang J, Yan B, Leng Y, Chen Z, Pan G, Xiang C, Teng Y.
    Bioorg Med Chem Lett; 2023 Apr 01; 85():129239. PubMed ID: 36924947
    [Abstract] [Full Text] [Related]

  • 13. Chalcones: Potential Chemotherapeutic Compounds and Educational Tools for Closing the Loop in STEM.
    Russell AE, Gines BR.
    Acc Chem Res; 2023 Jun 06; 56(11):1256-1262. PubMed ID: 36696370
    [Abstract] [Full Text] [Related]

  • 14. Design, synthesis, characterization and anticancer activity evaluation of deoxycholic acid-chalcone conjugates.
    Patel S, Challagundla N, Rajput RA, Mishra S.
    Bioorg Chem; 2022 Oct 06; 127():106036. PubMed ID: 35878450
    [Abstract] [Full Text] [Related]

  • 15. Apoptosis induction, PARP-1 inhibition, and cell cycle analysis of leukemia cancer cells treated with novel synthetic 1,2,3-triazole-chalcone conjugates.
    Othman EM, Fayed EA, Husseiny EM, Abulkhair HS.
    Bioorg Chem; 2022 Jun 06; 123():105762. PubMed ID: 35358822
    [Abstract] [Full Text] [Related]

  • 16. 3-Aminomethyl pyridine chalcone derivatives: Design, synthesis, DNA binding and cytotoxic studies.
    Durgapal SD, Soni R, Umar S, Suresh B, Soman SS.
    Chem Biol Drug Des; 2018 Jul 06; 92(1):1279-1287. PubMed ID: 29575807
    [Abstract] [Full Text] [Related]

  • 17. Structure-activity relationships reveal a 2-furoyloxychalcone as a potent cytotoxic and apoptosis inducer for human U-937 and HL-60 leukaemia cells.
    Del Rosario H, Saavedra E, Brouard I, González-Santana D, García C, Spínola-Lasso E, Tabraue C, Quintana J, Estévez F.
    Bioorg Chem; 2022 Oct 06; 127():105926. PubMed ID: 35717804
    [Abstract] [Full Text] [Related]

  • 18. Molecular Docking Study, Cytotoxicity, Cell Cycle Arrest and Apoptotic Induction of Novel Chalcones Incorporating Thiadiazolyl Isoquinoline in Cervical Cancer.
    Tantawy MA, Sroor FM, Mohamed MF, El-Naggar ME, Saleh FM, Hassaneen HM, Abdelhamid IA.
    Anticancer Agents Med Chem; 2020 Oct 06; 20(1):70-83. PubMed ID: 31696811
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and biological evaluation of novel ligustrazine-chalcone derivatives as potential anti-triple negative breast cancer agents.
    Luo Y, Wu W, Zha D, Zhou W, Wang C, Huang J, Chen S, Yu L, Li Y, Huang Q, Zhang J, Zhang C.
    Bioorg Med Chem Lett; 2021 Sep 01; 47():128230. PubMed ID: 34186178
    [Abstract] [Full Text] [Related]

  • 20. Synthesis and biological evaluation of 4-amino-5-cinnamoylthiazoles as chalcone-like anticancer agents.
    Ayati A, Esmaeili R, Moghimi S, Oghabi Bakhshaiesh T, Eslami-S Z, Majidzadeh-A K, Safavi M, Emami S, Foroumadi A.
    Eur J Med Chem; 2018 Feb 10; 145():404-412. PubMed ID: 29335206
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.